Ophthalmic genetics and Gene therapy Allied Academies Conferences

Ophthalmic genetics and Gene therapy

Gene therapy is an exploratory technique that employs genes to treat or prevent diseases. In near future, this technique may include a doctor replacing the mutated gene with a healthy copy of the gene to the patient in order to cure the abnormalities instead of surgery or drugs. Ophthalmic genetics is a branch of ophthalmology which refers to the field where the genetic background of disease is researched. Leber Congenital Amaraius(LCA) is a hereditary genetic disease that causes childhood blindness. Scientists and doctors have treated this disease with the help of gene therapy.

1. Genetics of Myopia Development
2. Gene Therapy
3. Usher syndrome
4. Familial exudative vitreal retinopathy
5. Retinoblastoma
6. Leber hereditary optic neuropathy (LHON)
7. Optic atrophy
8. Genetics of Myopia Development

Related Conferences: 4th International Conference on Ophthalmology and Eye Disorders, Nov 1-2, 2018, London UK; 3rd International Conference on Eye and Vision, August 21-23, 2017, Toronto Canada; 2nd Optometry and Vision Science Conference October 27-29, 2016 Rome, Italy; Paediatric Ophthalmology Congress June 6-7, 2016 London, UK; 8th Ophthalmology Conference July 18-20, 2016 Chicago, USA; Cataract and Refractive Surgery Conference August 04-05, 2016 Manchester, UK; 7th European Ophthalmology Conferences December 05-06, 2016 Madrid, Spain; 2nd Eye and Vision Conference September 26-28, 2016 Miami, USA; 9th Ophthalmic Conference October 24-26, 2016 Istanbul, Turkey; Ophthalmology Conference November 7-9, 2016 Melbourne, Australia.